Trial Profile

A Phase 1 clinical trial of Osca

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 12 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Nov 2025 New trial record
19 Mar 2025 According to the Kangstem Biotech media release, the results of the Oscar Phase 1 clinical trial, including MRI images, will be announced at the World Osteoarthritis Congress (OARSI) in Songdo in April, and the data and results at 12 months will be presented at the International Arthritis Sports Knee Society (ISAKOS) in Munich, Germany in June.
19 Mar 2025 According to the Kangstem Biotech media release,the company announced that it has completed a 12-month long-term follow-up visit for the high-dose group of the Phase 1 clinical trial of the osteoarthritis treatment 'OSCA'

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com